Adverum Biotechnologies Inc (ADVM) — Financial Flexibility Index
Adverum Biotechnologies Inc (ADVM) has a Financial Flexibility Index of -0.22x as of September 2025. Free cash flow of $-27.97 Million (operating CF $-28.11 Million minus capex $142.00K) represents 0% of total liabilities ($128.05 Million). Check ADVM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Adverum Biotechnologies Inc Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Adverum Biotechnologies Inc across 13 annual periods. For the full cash flow conversion analysis, see ADVM operating cash flow.
Annual Financial Flexibility Index for Adverum Biotechnologies Inc (2012–2024)
Year-by-year free cash flow to debt coverage for Adverum Biotechnologies Inc. Explore cash flow to debt ratio of Adverum Biotechnologies Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.84x | $-92.07 Million | $-92.46 Million | $109.13 Million | ▲ +17.1% |
| 2023 | -1.02x | $-90.09 Million | $-90.90 Million | $88.55 Million | ▼ -34.1% |
| 2022 | -0.76x | $-96.28 Million | $-108.09 Million | $126.85 Million | ▼ -1.1% |
| 2021 | -0.75x | $-92.71 Million | $-107.83 Million | $123.54 Million | ▲ +46.4% |
| 2020 | -1.40x | $-67.45 Million | $-79.29 Million | $48.22 Million | ▼ -123.3% |
| 2019 | -0.63x | $-29.92 Million | $-49.17 Million | $47.77 Million | ▲ +85.5% |
| 2018 | -4.31x | $-53.16 Million | $-53.96 Million | $12.33 Million | ▼ -73.6% |
| 2017 | -2.48x | $-44.41 Million | $-45.42 Million | $17.88 Million | ▼ -31.1% |
| 2016 | -1.89x | $-35.95 Million | $-38.37 Million | $18.98 Million | ▲ +31.3% |
| 2015 | -2.76x | $-32.35 Million | $-35.34 Million | $11.73 Million | ▼ -628.3% |
| 2014 | -0.38x | $-4.71 Million | $-5.65 Million | $12.42 Million | ▲ +76.3% |
| 2013 | -1.60x | $-2.08 Million | $-2.17 Million | $1.30 Million | ▼ -75.0% |
| 2012 | -0.91x | $-1.26 Million | $-1.27 Million | $1.38 Million | — |